Potato farmers on Prince Edward Island are encountering a fresh obstacle as they gear up for the 2026 planting season, distinct from the usual challenges of weather conditions and fertilizer expenses. The food industry landscape is undergoing transformation due to the increasing usage of GLP-1 agonists, a category of medications utilized in diabetes management and weight loss. This shift is influencing Canadians’ dietary habits and shopping behaviors, impacting their consumption of potatoes and related products such as chips and fries.
A recent national survey conducted by Dalhousie University’s Agri-Food Analytics Lab in late 2025 revealed a rising trend in the adoption of GLP-1 drugs among Canadians. Sylvain Charlebois, the lab’s director, disclosed that approximately 1.9 million Canadians are currently using GLP-1 medications, equivalent to the combined populations of New Brunswick and Manitoba. This figure is expected to climb further in the future.
Findings from the survey indicated that over half of the drug users are reducing their food intake, with 27% dining out less frequently and nearly 20% cutting back on grocery purchases. The economic impact on the Canadian food sector is estimated at over $3.3 billion in annual sales decline. Charlebois emphasized that the proliferation of generic versions of GLP-1 drugs poses a growing challenge for the potato industry in P.E.I., potentially affecting demand for alcohol, sugary items, and snacks, with traditional favorites like french fries being relegated as extras.
Stakeholders in P.E.I.’s potato sector have been closely monitoring developments related to GLP-1 drugs, with the topic featuring prominently in industry gatherings and marketing discussions. Jennifer Harris, representing the P.E.I. Potato Board and Island Growers Co., stressed the importance of highlighting the nutritional benefits of potatoes, which are often underrated despite being rich in essential nutrients like vitamin C, potassium, zinc, B6, and fiber.
Charlebois noted a surge in interest in protein-rich foods, leading to a decline in sales for lower-protein options like potatoes. However, he expressed optimism about the industry’s ability to adapt and innovate, suggesting the need for creative strategies to reposition potatoes in the evolving food landscape. Drawing parallels to the rising popularity of cottage cheese among younger demographics driven by social media, Charlebois underscored the importance of catering to the preferences of younger generations to revitalize the potato industry.
Ignoring the impact of GLP-1 drugs could prove costly for the Prince Edward Island industry observers, as highlighted by Harris, who emphasized the enduring appeal of potatoes as a wholesome and nutritious option. The evolving trends underscore the necessity for ongoing research and adaptation to meet changing consumer demands and preferences.